Table 1 Descriptive statistics of study population
|  | Pancreatic cancer N = 286 n (%) | No pancreatic cancer N = 61,311 n (%) |
|---|---|---|
Mean Age (years) (SD) | 59.8 (12.01) | 50.0 (15.94) |
  < 55 | 101 (35.3) | 38,417 (62.7) |
  ≥ 55 | 185 (64.7) | 22,894 (37.3) |
Gender | ||
 Men | 130 (45.5) | 26,717 (43.6) |
 Women | 156 (54.5) | 34,594 (56.4) |
SES | ||
 Unclassified/Missing | 53 (18.5) | 9701 (15.8) |
 Low | 99 (34.6) | 24,282 (39.6) |
 High | 134 (46.9) | 27,328 (44.6) |
Education | ||
 Missing | 39 (13.6) | 4213 (6.9) |
 Low | 68 (23.8) | 14,428 (23.5) |
 Middle | 104 (36.4) | 25,240 (41.2) |
 High | 75 (26.2) | 17,430 (28.4) |
Comorbidities | ||
 0 | 253 (88.5) | 56,346 (91.9) |
 1 | 27 (9.4) | 3476 (5.7) |
 2 | 3 (1.0) | 858 (1.4) |
 3+ | 3 (1.0) | 631 (1.0) |
 Mean follow-up time (years) (SD) | 10.2 (6.49) | 18.3 (5.53) |
Serum glucose (mmol/L) | ||
 Mean (SD) | 5.55 (2.02) | 5.06 (1.45) |
  < 5.6 mmol/L | 197 (68.9) | 50,219 (81.9) |
 5.6–6.9 mmol/L | 58 (20.3) | 7281 (11.9) |
  ≥ 7 mmol/L | 24 (8.4) | 2511 (4.1) |
 Missing | 7 (2.4) | 1300 (2.1) |
Albumin (g/L) | ||
 Mean (SD) | 41.73 (2.83) | 42.51 (2.90) |
  < 40 g/L | 55 (19.2) | 8678 (14.2) |
  ≥ 40 g/L | 231 (80.8) | 52,633 (85.8) |
Haptoglobin (g/L) | ||
 Mean (SD) | 1.20 (0.35) | 1.08 (0.32) |
  < 1.4 g/L | 199 (69.6) | 51,885 (84.6) |
  ≥ 1.4 g/L | 87 (30.4) | 9426 (15.4) |
C-reactive protein (mg/L) | ||
 Mean (SD) | 6.78 (10.74) | 5.56 (14.51) |
  < 10 mg/L | 217 (75.9) | 50,551 (82.5) |
  ≥ 10 mg/L | 69 (24.1) | 10,760 (17.5) |
Leukocytes (109 cells/L) | ||
 Mean (SD) | 7.42 (2.94) | 6.67 (2.29) |
  < 10 109 cells/L | 253 (88.5) | 57,330 (93.5) |
  ≥ 10 109 cells/L | 33 (11.6) | 3981 (6.5) |